References
Verma IC, Saxena R, Kohli S. Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res. 2011;134:507–21.
Mandal S, Sodhi KS, Bansal D, et al. MRI for quantification of liver and cardiac iron in thalassemia major patients: pilot study in Indian population. Indian J Pediatr. 2017;84:276–82.
Totadri S, Bansal D, Bhatia P, Attri SV, Trehan A, Marwaha RK. The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: a prospective, single center, open-label study. Pediatr Blood Cancer. 2015;62:1592–6.
Moirangthem A, Phadke SR. Socio-demographic profile and economic burden of treatment of transfusion dependent thalassemia. Indian J Pediatr. 2017; https://doi.org/10.1007/s12098-017-2478-y.
Esmaeilzadeh F, Azarkeivan A, Emamgholipour S, et al. Economic burden of thalassemia major in Iran, 2015. J Res Health Sci. 2016;16:111–5.
Weidlich D, Kefalas P, Guest JF. Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom. Transfusion. 2016;56:1038–45.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Bansal, D. Financial Burden of Treatment of Transfusion Dependent Thalassemia. Indian J Pediatr 85, 85–86 (2018). https://doi.org/10.1007/s12098-017-2547-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-017-2547-2